Linalool exerts antioxidant activity in a rat model of diabetes by increasing catalase activity without antihyperglycemic effect

Bar,Sezer; Kara,Mehmet

doi:10.3892/etm.2024.12648

Linalool exerts antioxidant activity in a rat model of diabetes by increasing catalase activity without antihyperglycemic effect

Authors:
- Sezer Bar
- Mehmet Kara
View Affiliations

Affiliations: Department of Medical Biochemistry, Medicine Faculty of Karabük University, 78000 Karabük, Turkey
Published online on: July 9, 2024 https://doi.org/10.3892/etm.2024.12648
Article Number: 359

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Diabetes mellitus (DM) is a prevalent metabolic disorder often accompanied by oxidative stress, which contributes to various diabetic complications. Investigating the antioxidant activity of linalool (LIN) is crucial as it may offer a natural therapeutic approach to mitigate oxidative damage in DM. The aim of the present study was to investigate the antioxidant activity of LIN in a DM rat model. A total of 40 male Wistar albino rats (age, 8 weeks; weight, 250‑300 g) were used. CONTROL and DM groups were administered physiological saline solution by oral gavage for 21 days. In rats in the DM + LIN and LIN groups, 100 mg/kg LIN was administered intragastrically after streptozotocin injection (n=10 per group). In the first (48 h after STZ injection), second (1 week later), third (2 weeks later), and fourth (3 weeks later) blood glucose measurements, a statistically significant increase was found in the blood glucose values of the DM and DM + LIN groups compared with those of the CONTROL group. During the 21‑day experimental period, there was no reduction in blood glucose levels of the DM + LIN group. Consequently, no discernible anti‑hyperglycemic effect of LIN was observed. Catalase enzyme activity, superoxide dismutase (SOD) enzyme activity, malondialdehyde (MDA) levels and glutathione (GSH) levels were measured spectrophotometrically. All assays were conducted according to the protocols provided in the respective kits. The results were analyzed to assess the oxidative status and antioxidant capacity in the experimental groups. Catalase (CAT) activity was decreased in the DM group compared with that in the CONTROL group in both the serum and liver. However, LIN administration restored CAT activity in the DM + LIN group to the level of the CONTROL group. In the liver, the DM + LIN‑treated group showed a notable reduction in malondialdehyde (MDA) levels compared with those in the DM group. In conclusion, the present results suggest that the antioxidant properties of LIN may have a regulatory effect on the oxidative status in diabetes‑affected systems, potentially offering therapeutic benefits in managing oxidative stress associated with diabetes.

View Figures

View References

1	American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 37 (Suppl 1):S81–S90. 2014.PubMed/NCBI View Article : Google Scholar
2	Sies H (ed): Oxidative Stress: Eustress and Distress. Academic Press, Cambridge, MA, 2019.
3	Darenskaya MA, Kolesnikova LI and Kolesnikov SI: Oxidative stress: Pathogenetic role in diabetes mellitus and its complications and therapeutic approaches to correction. Bull Exp Biol Med. 171:179–189. 2021.PubMed/NCBI View Article : Google Scholar
4	Sifuentes-Franco S, Pacheco-Moisés FP, Rodríguez-Carrizalez AD and Miranda-Díaz AG: The role of oxidative stress, mitochondrial function, and autophagy in diabetic polyneuropathy. J Diabetes Res. 2017(1673081)2017.PubMed/NCBI View Article : Google Scholar
5	Ozougwu JC: The role of reactive oxygen species and antioxidants in oxidative stress. Int J Res. 3:1–8. 2016.
6	Mirończuk-Chodakowska I, Witkowska AM and Zujko ME: Endogenous non-enzymatic antioxidants in the human body. Adv Med Sci. 63:68–78. 2018.PubMed/NCBI View Article : Google Scholar
7	Miguel MG: Antioxidant and anti-inflammatory activities of essential oils: A short review. Molecules. 15:9252–9287. 2010.PubMed/NCBI View Article : Google Scholar
8	Blowman K, Magalhães M, Lemos MFL, Cabral C and Pires IM: Anticancer properties of essential oils and other natural products. Evid Based Complement Alternat Med. 2018(3149362)2018.PubMed/NCBI View Article : Google Scholar
9	Tomaino A, Cimino F, Zimbalatti V, Venuti V, Sulfaro V, De Pasquale A and Saija A: Influence of heating on antioxidant activity and the chemical composition of some spice essential oils. Food Chem. 89:549–554. 2005.
10	Edris AE: Pharmaceutical and therapeutic potentials of essential oils and their individual volatile constituents: A review. Phytother Res. 21:308–323. 2007.PubMed/NCBI View Article : Google Scholar
11	Lapczynski A, Letizia C and Api A: Addendum to fragrance material review on linalool. Food Chem Toxicol. 46 (Suppl 11):S190–S192. 2008.PubMed/NCBI View Article : Google Scholar
12	Kamatou GPP and Viljoen AM: Linalool-A review of a biologically active compound of commercial importance. Nat Prod Commun. 3(1187)2008.
13	Aprotosoaie AC, Hăncianu M, Costache II and Miron A: Linalool: A review on a key odorant molecule with valuable biological properties. Flavour Fragr J. 29:193–219. 2014.
14	de Cássia da Silveira e Sá R, Andrade LN and de Sousa DP: A review on anti-inflammatory activity of monoterpenes. Molecules. 18:1227–1254. 2013.PubMed/NCBI View Article : Google Scholar
15	Tit DM and Bungau SG: Antioxidant activity of essential oils. Antioxidants (Basel). 12(383)2023.PubMed/NCBI View Article : Google Scholar
16	Chen X, Shang S, Yan F, Jiang H, Zhao G, Tian S, Chen R, Chen D and Dang Y: Antioxidant activities of essential oils and their major components in scavenging free radicals, inhibiting lipid oxidation and reducing cellular oxidative stress. Molecules. 28(4559)2023.PubMed/NCBI View Article : Google Scholar
17	Sökmen M, Serkedjieva J, Daferera D, Gulluce M, Polissiou M, Tepe B, Akpulat HA, Sahin F and Sokmen A: In vitro antioxidant, antimicrobial, and antiviral activities of the essential oil and various extracts from herbal parts and callus cultures of Origanum acutidens. J Agric Food Chem. 52:3309–3312. 2004.PubMed/NCBI View Article : Google Scholar
18	Lin KH, Yeh SY, Lin MY, Shih MC, Yang KTU and Hwang SY: Major chemotypes and antioxidative activity of the leaf essential oils of Cinnamomum osmophloeum Kaneh. from a clonal orchard. Food Chem. 105:133–139. 2007.
19	van Zyl RL, Seatlholo ST, van Vuuren SF and Viljoen AM: The Biological activities of 20 nature identical essential oil constituents. Journal of Essential Oil Research. 18 (Suppl 1):S129–S133. 2006.
20	Gunaseelan S, Balupillai A, Govindasamy K, Ramasamy K, Muthusamy G, Shanmugam M, Thangaiyan R, Robert BM, Prasad Nagarajan R, Ponniresan VK and Rathinaraj P: Linalool prevents oxidative stress activated protein kinases in single UVB-exposed human skin cells. PLoS One. 12(e0176699)2017.PubMed/NCBI View Article : Google Scholar
21	Migheli R, Lostia G, Galleri G, Rocchitta G, Serra PA, Bassareo V, Acquas E and Peana AT: Neuroprotective effect of (R)-(-)-linalool on oxidative stress in PC12 cells. Phytomed Plus. 1(100073)2021.
22	Vavra JJ, Deboer C, Dietz A, Hanka LJ and Sokolski WT: Streptozotocin, a new antibacterial antibiotic. Antibiot Annu. 7:230–235. 1959.PubMed/NCBI
23	Rakieten N, Rakieten ML and Nadkarni MV: Studies on the diabetogenic action of streptozotocin (NSC-37917). Cancer Chemother Rep. 29:91–98. 1963.PubMed/NCBI
24	Ghasemi A and Jeddi S: Streptozotocin as a tool for induction of rat models of diabetes: A practical guide. EXCLI J. 22:274–294. 2023.PubMed/NCBI View Article : Google Scholar
25	Elsner M, Guldbakke B, Tiedge M, Munday R and Lenzen S: Relative importance of transport and alkylation for pancreatic beta-cell toxicity of streptozotocin. Diabetologia. 43:1528–1533. 2000.PubMed/NCBI View Article : Google Scholar
26	Gunnarsson R, Berne C and Hellerström C: Cytotoxic effects of streptozotocin and N-nitrosomethylurea on the pancreatic B cells with special regard to the role of nicotinamide-adenine dinucleotide. Biochem J. 140:487–494. 1974.PubMed/NCBI View Article : Google Scholar
27	Huo M, Cui X, Xue J, Chi G, Gao R, Deng X, Guan S, Wei J, Soromou LW, Feng H and Wang D: Anti-inflammatory effects of linalool in RAW 264.7 macrophages and lipopolysaccharide-induced lung injury model. J Surg Res. 180:e47–e54. 2013.PubMed/NCBI View Article : Google Scholar
28	Sun XB, Wang SM, Li T and Yang Y: Anticancer activity of linalool terpenoid: apoptosis induction and cell cycle arrest in prostate cancer cells. Trop J Pharm Res. 14:619–625. 2015.
29	Cho SY, Jun HJ, Lee JH, Jia Y, Kim KH and Lee SJ: Linalool reduces the expression of 3-hydroxy-3-methylglutaryl CoA reductase via sterol regulatory element binding protein-2- and ubiquitin-dependent mechanisms. FEBS Lett. 585:3289–3296. 2011.PubMed/NCBI View Article : Google Scholar
30	Herman A, Tambor K and Herman A: Linalool affects the antimicrobial efficacy of essential oils. Curr Microbiol. 72:165–172. 2016.PubMed/NCBI View Article : Google Scholar
31	Katsuyama S, Kuwahata H, Yagi T, Kishikawa Y, Komatsu T, Sakurada T and Nakamura H: Intraplantar injection of linalool reduces paclitaxel-induced acute pain in mice. Biomed Res. 33:175–181. 2012.PubMed/NCBI View Article : Google Scholar
32	Asmat U, Abad K and Ismail K: Diabetes mellitus and oxidative stress-a concise review. Saudi Pharm J. 24:547–553. 2016.PubMed/NCBI View Article : Google Scholar
33	Furman BL: Streptozotocin-induced diabetic models in mice and rats. Curr Protoc. 1(e78)2021.PubMed/NCBI View Article : Google Scholar
34	Fararh KM, Shimizu Y, Shiina T, Nikami H, Ghanem MM and Takewaki T: Thymoquinone reduces hepatic glucose production in diabetic hamsters. Res Vet Sci. 79:219–223. 2005.PubMed/NCBI View Article : Google Scholar
35	Faisal Lutfi M, Abdel-Moneim AH, Alsharidah AS, Mobark MA, Abdellatif AAH, Saleem IY, Al Rugaie O, Mohany KM and Alsharidah M: Thymoquinone lowers blood glucose and reduces oxidative stress in a rat model of diabetes. Molecules. 26(2348)2021.PubMed/NCBI View Article : Google Scholar
36	Altınok-Yipel F, Tekeli İO, Özsoy ŞY, Güvenç M, Kaya A and Yipel M: Hepatoprotective activity of linalool in rats against liver injury induced by carbon tetrachloride. Int J Vitam Nutr Res. 90:302–308. 2020.PubMed/NCBI View Article : Google Scholar
37	Deeds MC, Anderson JM, Armstrong AS, Gastineau DA, Hiddinga HJ, Jahangir A, Eberhardt NL and Kudva YC: Single dose streptozotocin-induced diabetes: Considerations for study design in islet transplantation models. Lab Anim. 45:131–140. 2011.PubMed/NCBI View Article : Google Scholar
38	Bhatia A, Saikia PP, Dkhar B and Pyngrope H: Anesthesia protocol for ear surgery in Wistar rats (animal research). Animal Model Exp Med. 5:183–188. 2022.PubMed/NCBI View Article : Google Scholar
39	Banday MZ, Sameer AS and Nissar S: Pathophysiology of diabetes: An overview. Avicenna J Med. 10:174–188. 2020.PubMed/NCBI View Article : Google Scholar
40	Pizzino G, Irrera N, Cucinotta M, Pallio G, Mannino F, Arcoraci V, Squadrito F, Altavilla D and Bitto A: Oxidative stress: Harms and benefits for human health. Oxid Med Cell Longev. 2017(8416763)2017.PubMed/NCBI View Article : Google Scholar
41	Caturano A, D'Angelo M, Mormone A, Russo V, Mollica MP, Salvatore T, Galiero R, Rinaldi L, Vetrano E, Marfella R, et al: Oxidative stress in type 2 diabetes: impacts from pathogenesis to lifestyle modifications. Curr Issues Mol Biol. 45:6651–6666. 2023.PubMed/NCBI View Article : Google Scholar
42	González P, Lozano P, Ros G and Solano F: Hyperglycemia and oxidative stress: An integral, updated and critical overview of their metabolic interconnections. Int J Mol Sci. 24(9352)2023.PubMed/NCBI View Article : Google Scholar
43	Khalid M, Petroianu G and Adem A: Advanced glycation end products and diabetes mellitus: Mechanisms and perspectives. Biomolecules. 12(542)2022.PubMed/NCBI View Article : Google Scholar
44	Vats V, Yadav SP and Grover JK: Ethanolic extract of Ocimum sanctum leaves partially attenuates streptozotocin-induced alterations in glycogen content and carbohydrate metabolism in rats. J Ethnopharmacol. 90:155–160. 2004.PubMed/NCBI View Article : Google Scholar
45	More TA, Kulkarni BR, Nalawade ML and Arvindekar AU: antidiabetic activity of linalool and limonene in streptozotocin-induced diabetic rat: A combinatorial therapy approach. Int J Pharm Pharm Sci. 6:159–163. 2014.
46	Garba HA, Mohammed A, Ibrahim MA and Shuaibu MN: Effect of lemongrass (Cymbopogon citratus Stapf) tea in a type 2 diabetes rat model. Clin Phytosci. 6(19)2020.
47	Tran N, Pham B and Le L: Bioactive compounds in anti-diabetic plants: From herbal medicine to modern drug discovery. Biology (Basel). 9(252)2020.PubMed/NCBI View Article : Google Scholar
48	Camargo SB, Simões LO, Medeiros CFA, de Melo Jesus A, Fregoneze JB, Evangelista A, Villarreal CF, Araújo AAS, Quintans-Júnior LJ and Silva DF: Antihypertensive potential of linalool and linalool complexed with β-cyclodextrin: Effects of subchronic treatment on blood pressure and vascular reactivity. Biochem Pharmacol. 151:38–46. 2018.PubMed/NCBI View Article : Google Scholar
49	Lee SC, Xu WX, Lin LY, Yang JJ and Liu CT: Chemical composition and hypoglycemic and pancreas-protective effect of leaf essential oil from indigenous cinnamon (Cinnamomum osmophloeum Kanehira). J Agric Food Chem. 61:4905–4913. 2013.PubMed/NCBI View Article : Google Scholar
50	Deepa B and Venkatraman Anuradha C: Effects of linalool on inflammation, matrix accumulation and podocyte loss in kidney of streptozotocin-induced diabetic rats. Toxicol Mech Methods. 23:223–234. 2013.PubMed/NCBI View Article : Google Scholar
51	Peana AT, D'Aquila PS, Panin F, Serra G, Pippia P and Moretti MD: Anti-inflammatory activity of linalool and linalyl acetate constituents of essential oils. Phytomedicine. 9:721–726. 2002.PubMed/NCBI View Article : Google Scholar
52	Peuchant E, Delmas-Beauvieux MC, Couchouron A, Dubourg L, Thomas MJ, Perromat A, Clerc M and Gin H: Short-term insulin therapy and normoglycemia. Effects on erythrocyte lipid peroxidation in NIDDM patients. Diabetes Care. 20:202–207. 1997.PubMed/NCBI View Article : Google Scholar
53	Kesavulu M, Rao BK, Giri R, Vijaya J, Subramanyam G and Apparao C: Lipid peroxidation and antioxidant enzyme status in type 2 diabetics with coronary heart disease. Diabetes Res Clin Pract. 53:33–39. 2001.PubMed/NCBI View Article : Google Scholar
54	Sözmen EY, Sözmen B, Delen Y and Onat T: Catalase/superoxide dismutase (SOD) and catalase/paraoxonase (PON) ratios may implicate poor glycemic control. Arch Med Res. 32:283–287. 2001.PubMed/NCBI View Article : Google Scholar
55	Kimura F, Hasegawa G, Obayashi H, Adachi T, Hara H, Ohta M, Fukui M, Kitagawa Y, Park H, Nakamura N, et al: Serum extracellular superoxide dismutase in patients with type 2 diabetes: Relationship to the development of micro- and macrovascular complications. Diabetes Care. 26:1246–1250. 2003.PubMed/NCBI View Article : Google Scholar
56	Ciechanowski K, Kedzierska K, Gołembiewska E, Safranow K, Bober J, Domański L, Rózański J and Myślak M: Impaired synthesis is not the reason for decreased activity of extracellular superoxide dismutase in patients with diabetes. Arch Med Res. 36:148–153. 2005.PubMed/NCBI View Article : Google Scholar
57	Lobo V, Patil A, Phatak A and Chandra N: Free radicals, antioxidants and functional foods: Impact on human health. Pharmacogn Rev. 4:118–126. 2010.PubMed/NCBI View Article : Google Scholar
58	Bhattacharyya A, Chattopadhyay R, Mitra S and Crowe SE: Oxidative stress: An essential factor in the pathogenesis of gastrointestinal mucosal diseases. Physiol Rev. 94:329–354. 2014.PubMed/NCBI View Article : Google Scholar
59	Mehri S, Meshki MA and Hosseinzadeh H: Linalool as a neuroprotective agent against acrylamide-induced neurotoxicity in Wistar rats. Drug Chem Toxicol. 38:162–166. 2015.PubMed/NCBI View Article : Google Scholar
60	Gaweł S, Wardas M, Niedworok E and Wardas P: Malondialdehyde (MDA) as a lipid peroxidation marker. Wiad Lek. 57:453–455. 2004.PubMed/NCBI(In Polish).